BioVie Inc. Net Change in Cash
BioVie Inc. (BIVI) reported Net Change in Cash of $20.00 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-05-11.
Discontinued › Cash Flow
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2022-05-11
- BioVie Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2021-12-31 was $9.90M.
- BioVie Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2021-09-30 was $15.98M, a 21.42% increase year-over-year.
- BioVie Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2021-06-30 was -$6.84M, a 20528.96% decline year-over-year.
- BioVie Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2021-03-31 was -$524.96K, a 86584.51% decline year-over-year.
- BioVie Inc. cash and cash equivalents, period increase (decrease) for fiscal 2021 was $4.47M.
- BioVie Inc. cash and cash equivalents, period increase (decrease) for fiscal 2020 was -$302.73K, a 202.93% decline from fiscal 2019.
- BioVie Inc. cash and cash equivalents, period increase (decrease) for fiscal 2019 was $294.12K, a 623.41% increase from fiscal 2018.
- BioVie Inc. cash and cash equivalents, period increase (decrease) for fiscal 2018 was $40.66K.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 3 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|---|---|
| 2022-09-30 | $20.00M 10-Q · filed 2022-05-11 | |||||
| 2021-12-31 | $9.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-08 | $25.88M 10-Q · filed 2022-02-08 | $19.04M derived: sum of 3 quarters · filed 2022-02-08 | $18.52M derived: sum of 4 quarters · filed 2022-02-08 | ||
| 2021-09-30 | $15.98M 10-Q · filed 2021-11-10 | $9.14M derived: sum of 2 quarters · filed 2021-11-10 | $11.31M 10-Q · filed 2022-05-11 | $7.29M derived: sum of 4 quarters · filed 2022-02-08 | ||
| 2021-06-30 | -$6.84M derived: 10-K 12 month − 10-Q 9 month · filed 2021-08-30 | -$7.36M derived: sum of 2 quarters · filed 2021-08-30 | -$8.68M derived: sum of 3 quarters · filed 2022-02-08 | $4.47M 10-K · filed 2021-08-30 | ||
| 2021-03-31 | -$524.96K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-10 | -$1.84M derived: sum of 2 quarters · filed 2022-02-08 | $11.31M 10-Q · filed 2021-05-10 | $11.35M derived: sum of 4 quarters · filed 2022-02-08 | ||
| 2020-12-31 | -$1.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-08 | $11.84M 10-Q · filed 2022-02-08 | $11.87M derived: sum of 3 quarters · filed 2022-02-08 | $11.87M derived: sum of 4 quarters · filed 2022-02-08 | ||
| 2020-09-30 | $13.16M 10-Q · filed 2021-11-10 | $13.19M derived: sum of 2 quarters · filed 2021-11-10 | $13.19M derived: sum of 3 quarters · filed 2021-11-10 | $12.95M derived: sum of 4 quarters · filed 2021-11-10 | ||
| 2020-06-30 | $33.48K derived: 10-K 12 month − 10-Q 9 month · filed 2021-08-30 | $34.09K derived: sum of 2 quarters · filed 2021-08-30 | -$211.81K derived: sum of 3 quarters · filed 2021-08-30 | -$302.73K 10-K · filed 2021-08-30 | ||
| 2020-03-31 | $607.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-10 | -$245.29K derived: sum of 2 quarters · filed 2021-05-10 | -$336.21K 10-Q · filed 2021-05-10 | -$967.90K derived: sum of 4 quarters · filed 2021-05-10 | ||
| 2019-12-31 | -$245.90K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-01-29 | -$336.81K 10-Q · filed 2021-01-29 | -$968.51K derived: sum of 3 quarters · filed 2021-01-29 | -$1.63M derived: sum of 4 quarters · filed 2021-01-29 | ||
| 2019-09-30 | -$90.91K 10-Q · filed 2020-11-05 | -$722.61K derived: sum of 2 quarters · filed 2020-11-05 | -$1.38M derived: sum of 3 quarters · filed 2020-11-05 | -$1.89M derived: sum of 4 quarters · filed 2020-11-05 | ||
| 2019-06-30 | -$631.69K derived: 10-K/A 12 month − 10-Q 9 month · filed 2020-08-07 | -$1.29M derived: sum of 2 quarters · filed 2020-08-07 | -$1.80M derived: sum of 3 quarters · filed 2020-08-07 | $294.12K 10-K/A · filed 2020-08-07 | ||
| 2019-03-31 | -$658.87K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-13 | -$1.16M derived: sum of 2 quarters · filed 2020-05-13 | $925.81K 10-Q · filed 2020-05-13 | $943.53K derived: sum of 4 quarters · filed 2020-05-13 | ||
| 2018-12-31 | -$505.13K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-13 | $1.58M 10-Q · filed 2020-02-13 | $1.58M 10-Q · filed 2019-02-12 | $1.60M derived: sum of 3 quarters · filed 2020-02-13 | $1.63M derived: sum of 4 quarters · filed 2020-02-13 | |
| 2018-09-30 | $2.09M 10-Q · filed 2019-11-19 | $2.11M derived: sum of 2 quarters · filed 2019-11-19 | $2.13M derived: sum of 3 quarters · filed 2019-11-19 | $2.11M derived: sum of 4 quarters · filed 2019-11-19 | ||
| 2018-06-30 | $17.72K derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-27 | $43.97K derived: sum of 2 quarters · filed 2019-09-27 | $24.09K derived: sum of 3 quarters · filed 2019-09-27 | $40.66K 10-K · filed 2019-09-27 | ||
| 2018-03-31 | $26.26K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-10 | $6.38K derived: sum of 2 quarters · filed 2019-05-10 | $22.94K 10-Q · filed 2019-05-10 | -$7.23K derived: sum of 4 quarters · filed 2019-05-10 | ||
| 2017-12-31 | -$19.88K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-12 | -$3.32K 10-Q · filed 2019-02-12 | -$33.48K derived: sum of 3 quarters · filed 2019-02-12 | -$2.69K derived: sum of 4 quarters · filed 2019-02-12 | ||
| 2017-09-30 | $16.56K 10-Q · filed 2018-11-14 | $16.57K 10-Q · filed 2017-11-08 | -$13.60K derived: sum of 2 quarters · filed 2018-11-14 | $17.19K derived: sum of 3 quarters · filed 2018-11-14 | $12.96K derived: sum of 4 quarters · filed 2018-11-14 | |
| 2017-06-30 | -$30.17K derived: 10-K 12 month − 10-Q 9 month · filed 2018-10-05 | $622.00 derived: sum of 2 quarters · filed 2018-10-05 | -$3.60K derived: sum of 3 quarters · filed 2018-10-05 | -$118.62K 10-K · filed 2018-10-05 | ||
| 2017-03-31 | $30.79K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-14 | $26.56K derived: sum of 2 quarters · filed 2018-05-14 | -$88.45K 10-Q · filed 2018-05-14 | -$197.94K derived: sum of 4 quarters · filed 2018-05-14 | ||
| 2016-12-31 | -$4.23K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-14 | -$119.24K 10-Q · filed 2018-02-14 | -$228.72K derived: sum of 3 quarters · filed 2018-02-14 | -$245.04K derived: sum of 4 quarters · filed 2018-02-14 | ||
| 2016-09-30 | -$115.01K 10-Q · filed 2017-11-08 | -$224.50K derived: sum of 2 quarters · filed 2017-11-08 | -$240.81K derived: sum of 3 quarters · filed 2017-11-08 | -$256.77K derived: sum of 4 quarters · filed 2017-11-08 | ||
| 2016-06-30 | -$109.49K derived: 10-K 12 month − 10-Q 9 month · filed 2017-08-24 | -$125.80K derived: sum of 2 quarters · filed 2017-08-24 | -$141.76K derived: sum of 3 quarters · filed 2017-08-24 | -$143.72K 10-K · filed 2017-08-24 | ||
| 2016-03-31 | -$16.31K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-09 | -$32.27K derived: sum of 2 quarters · filed 2017-05-09 | -$34.24K 10-Q · filed 2017-05-09 | -$45.29K derived: sum of 4 quarters · filed 2017-05-09 | ||
| 2015-12-31 | -$15.96K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2017-02-07 | -$17.93K 10-Q · filed 2017-02-07 | -$28.98K derived: sum of 3 quarters · filed 2017-02-07 | -$38.51K derived: sum of 4 quarters · filed 2017-02-07 | ||
| 2015-09-30 | -$1.97K 10-Q/A · filed 2017-01-19 | -$13.02K derived: sum of 2 quarters · filed 2017-01-19 | -$22.55K derived: sum of 3 quarters · filed 2017-01-19 | -$52.63K derived: sum of 4 quarters · filed 2017-01-19 | ||
| 2015-06-30 | -$11.05K derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-28 | -$20.59K derived: sum of 2 quarters · filed 2016-09-28 | -$50.67K derived: sum of 3 quarters · filed 2016-09-28 | -$65.38K 10-K · filed 2016-09-28 | ||
| 2015-03-31 | -$9.53K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-23 | -$39.61K derived: sum of 2 quarters · filed 2016-05-23 | -$54.33K 10-Q · filed 2016-05-23 | -$66.72K derived: sum of 4 quarters · filed 2016-05-23 | ||
| 2014-12-31 | -$30.08K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-16 | -$44.80K 10-Q · filed 2016-02-16 | -$57.19K derived: sum of 3 quarters · filed 2016-02-16 | -$118.76K derived: sum of 4 quarters · filed 2016-02-16 | ||
| 2014-09-30 | -$14.72K 10-Q · filed 2015-11-13 | -$27.11K derived: sum of 2 quarters · filed 2015-11-13 | -$88.68K derived: sum of 3 quarters · filed 2015-11-13 | -$127.70K derived: sum of 4 quarters · filed 2015-11-13 | ||
| 2014-06-30 | -$12.39K derived: 10-K 12 month − 10-Q 9 month · filed 2015-10-01 | -$73.96K derived: sum of 2 quarters · filed 2015-10-01 | -$112.98K derived: sum of 3 quarters · filed 2015-10-01 | -$172.83K 10-K · filed 2015-10-01 | ||
| 2014-03-31 | -$61.57K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-11 | -$100.59K derived: sum of 2 quarters · filed 2015-05-11 | -$160.44K 10-Q · filed 2015-05-11 | $345.25K 10-Q · filed 2014-05-09 | ||
| 2013-12-31 | -$39.02K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-05 | -$98.87K 10-Q · filed 2015-02-05 | ||||
| 2013-09-30 | -$59.85K 10-Q · filed 2014-11-13 | |||||
| 2013-06-30 | $505.70K 10-K · filed 2014-09-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |